Pancreatic Cancer
Pancreatic cancer is the fifth leading cause of cancer death in Western societies, with a five year survival rate of less than 10%. The treatment and survival of patients with pancreatic cancer has not changed for over thirty years because there has been little research into the molecular and cell biology associated with it. Our projects focus on translating basic scientific discoveries into the clinic. These include:
- Defining clinically and biologically relevant phenotypes of Pancreatic Cancer, primarily through our integral role in the Australian Pancreatic Cancer Genome Initiative which is part of the International Cancer Genome Consortium (see http://www.pancreaticcancer.net.au)
- Developing biomarkers of prognosis and therapeutic responsiveness with clinical utility
- Understanding molecular mechanisms of resistance to develop novel therapeutic strategies.
Staff
 Senior Research
OfficerDr Chris Scarlett |
 Research AssistantAmanda Mawson |
 Research AssistantMark Pinese |
 PhD StudentDr David Chang |
 PhD StudentJohana Susanto |
 Clinical Research
CoordinatorAmber Johns |
 Postgraduate StudentEmily Colvin |
 Clinical Research CoordinatorMichelle Thomas |
 Administration AssistantCathy Axford |
 Technical OfficerMary-Anne Bracato |
 Clinical Nurse ConsultantGlenn Downes |
|
| Visiting Scientists A/Prof James Kench A/Prof Neil Merrett Dr Anthony Gill |
Data Clerks Tehara Wickremeratne |
News
Emily Colvin wins Premier’s Award for Outstanding Cancer Research Scholar
26 May 2009
Garvan PhD student Emily Colvin has received the prestigious $10,000 Premier's Award for Outstanding Cancer Research Scholar from the Cancer Institute NSW for her research into pancreatic cancer. The news was announced at a gala ceremony late last week.
Nuns on the Run from Dubbo to Darlinghurst for Cancer
MEDIA RELEASE:
19 Apr 2009
Led by two Sisters of Charity, The Nuns’ Run will cover the 400 km distance from Dubbo to Darlinghurst in an effort to raise cancer awareness and crucial funds for the establishment of a new $100 million Cancer Centre within the St Vincent’s Research Precinct, Sydney. Embarking on their journey on 24 May, Sisters Helen Clarke and Leone Wittmack are hoping to arrive in Sydney on 5 June.
Garvan to play a role in International Cancer Genome Consortium
MEDIA RELEASE:
26 Mar 2009
Garvan scientists will play an integral role in Australia’s contribution towards the International Cancer Genome Consortium, the details of which were announced today by Minister for Health and Ageing, The Hon. Nicola Roxon MP. They will be part of a team tackling pancreatic cancer, one of the deadliest cancers.
